A new study has revealed that mechanically retrieving blood clots from medium- or small-sized brain arteries did not improve ...

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

A prehospital blood test may rapidly distinguish between ischemic and hemorrhagic strokes, potentially enabling more timely, ...

Are you having problems in memory, attention, and multitasking because of a traumatic brain injury (blow or blast to the head) and not from a stroke or something else? If this is you and you are ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Professor Martin James has been recognised nationally for his pioneering stroke research, including AI-driven treatments and ...

Learn why people often dismiss stroke warning signs, how psychological barriers delay treatment, and what actions can save ...

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...

A new study has found that the clot-dissolving drug alteplase can significantly improve stroke recovery even when given up to ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Researchers continue to advance the science to determine best treatments for stroke. Based on an international study of 530 patients, researchers discovered that while the clot retrieval procedure ...

Johnson & Johnson aims to streamline operations by selling its stroke care business, Cerenovus, valued at $1B+.